The Emerging Role of Dipeptidyl-Peptidase-4 as a Therapeutic Target in Lung Disease

Expert Opinion on Therapeutic Targets - United Kingdom
doi 10.1080/14728222.2020.1721468
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Dipeptidyl Peptidase-4 (DPP-4; CD26)

Science-Business eXchange
2014English

The Nonglycemic Actions of Dipeptidyl Peptidase-4 Inhibitors

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2014English

Navigating the Chemical Space of Dipeptidyl Peptidase-4 Inhibitors

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2015English

Dipeptidyl Peptidase-4 Inhibitor-Associated Bullous Pemphigoid

2019English

The Importance of TSLP in Allergic Disease and Its Role as a Potential Therapeutic Target

Expert Review of Clinical Immunology
AllergyImmunology
2014English

The Effects of Dipeptidyl Peptidase-4 Inhibition on Microvascular Diabetes Complications

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2014English

Role of Incretin, Incretin Analogues and Dipeptidyl Peptidase 4 Inhibitors in the Pathogenesis and Treatment of Diabetes Mellitus

2011English

Long-Term Inhibition of Dipeptidyl Peptidase-4 in Alzheimer’s Prone Mice

Experimental Gerontology
AgingGeneticsCell BiologyMolecular BiologyBiochemistryEndocrinology
2010English

Dipeptidyl Peptidase 4 (Dpp-4) Inhibitors for the Treatment of Type 2 Diabetes Mellitus

Journal of thee Medical Sciences (Berkala Ilmu Kedokteran)
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy